Biologics: Targets and Therapy
Volume 6, 2012 - Issue
Open access
100
Views
4
CrossRef citations to date
0
Altmetric
Review
Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
Marc C Smaldone1 Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USACorrespondence[email protected]
, David YT Chen1 Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
, Jian Q Yu2 Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, PA, USA
& Elizabeth R Plimack3 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Pages 395-407
|
Published online: 19 Nov 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.